Efficacy of selected dietary supplements and pharmacological agents on metabolic and oxidative stress outcomes in metabolic dysfunction–associated fatty liver disease (MAFLD): a Bayesian network meta-analysis

Key Points

• Selected dietary supplements and pharmacological agents improve metabolic and oxidative stress outcomes in fatty liver disease.
• The analysis finds strong efficacy of various interventions, with noted improvements in key metabolic markers.
• Bayesian network meta-analysis was conducted to compare the effectiveness of dietary supplements and pharmacological agents for MAFLD.
• These findings highlight potential treatment options for MAFLD, emphasizing the importance of further clinical investigations.

Abstract